Hidrasec Dosage/Direction for Use

Capsule: Oral route.
Adults: In the treatment of acute diarrhoea, the treatment should be initiated with a single 100 mg capsule given regardless of the time, further treatment is a single 100 mg capsule at the beginning of the three main meals.
The administration of HIDRASEC capsules does not exempt of rehydration therapy if necessary. The duration of treatment must not exceed seven days.
Specific populations: Paediatric population: Hidrasec 100 mg capsules must not be administered to infants and children.
Other pharmaceutical forms of Hidrasec suitable for the paediatric population are available.
Elderly: Dosage adjustment is not necessary in the elderly (see Pharmacology: Pharmacokinetics under Actions).
Caution is advised in patients with hepatic or renal impairment.
Granules for oral suspension: Posology: The usual daily dose is determined according to bodyweight on the basis of 1.5 mg/kg per dose, with one initial dose and then 3 doses spread over the day.
In practice: Number of sachet(s) per dose according to child's weight: Hidrasec Infants: See Table 1.

Click on icon to see table/diagram/image

Hidrasec Children: See Table 2.

Click on icon to see table/diagram/image

Treatment regimen: On the 1st day: One starting dose and then 3 doses spread throughout the day. Subsequent days: 3 doses spread throughout the day.
The powder should be swallowed as it is. It can also be added to food or poured into a glass of water or a feeding bottle, stirring well and ensuring that all the mixture is swallowed immediately.
On the basis of the dosage stated previously, the recommended daily dose is about 6 mg/kg, i.e. about 42 mg/kg for one week of treatment.
Method of administration: The powder can be poured either onto food or into a glass of water or feeding bottle; stirring well and ensuring that the whole of the mixture is swallowed immediately.
Treatment must be continued until the return of two normal stools, but should not exceed 7 days.
Specific populations: No studies have been conducted in children less than 3 months old.
No studies have been conducted in children with hepatic or renal insufficiency (see Precautions).